https://www.selleckchem.com/pr....oducts/msdc-0160.htm
No NTNG1 autoantibodies were identified in 561 PLA R1 autoantibodies-positive patients, 27 THSD7A autoantibodies-positive patients, and 77 patients with other glomerular diseases. In two patients with available follow-up of 2 and 4 years, both NTNG1 autoantibodies and proteinuria persisted. NTNG1 expands the repertoire of target antigens in patients with MN. The clinical role of NTNG1 autoantibodies remains to be defined. NTNG1 expands the repertoire of target antigens in patients with MN. The clinical role of NTNG1 autoantibodies rem
Like
Comment
Share
